PFA Investor Call Intimation.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the exchanges that it will release its Q4 FY2025 audited financial results on 30th April 2025, followed by an earnings conference call at 4:30 PM IST the same day. The call, to be addressed by the company's leadership team, will cover financial performance and include a Q&A session. The filing is being re-uploaded to BSE as the original intimation did not appear on the BSE portal earlier. International dial-in access is being provided for investors across the US, UK, Singapore, and Hong Kong.
This is a routine procedural disclosure and has no direct impact on the stock price. Investors should watch the Q4 results and management commentary on 30th April for cues on revenue growth, margins, and FY26 outlook.